Institut de Cancérologie du Gard - Hématologie Clinique

Nîmes 30029

0 studies enrolling now · 1 studies all time

What they study most

Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Studies at this site

• A Multicenter Phase 3, Open-Label Study of Bosutinib Versus Imatinib in Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia — Completed